Multidrug resistance, biofilm formation, and genetic determinants in diabetic foot infections from Uttar Pradesh, India: a clinical-microbiological insight from a prospective study
- 23 May 2025
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 398 (11) , 15965-15981
Abstract
This prospective cohort study systematically analyzed the demographic profile, clinical characteristics, spectrum of microorganisms, and antimicrobial resistance pattern in 248 patients with diabetic foot ulcer (DFU) over 2.7 years. Most patients were male (75.4%) and had a mean age of 56.1 years, and high comorbidity rates (81% neuropathy, 77% retinopathy, and 67.7% hypertension). A combined 439 bacterial isolates were obtained, with the dominance of Gram-negative pathogens, including Escherichia coli (16.6%) and Pseudomonas aeruginosa (15.3%). Staphylococcus aureus was also the dominant Gram-positive pathogen (12.8%). Polymicrobial infections were found in 43.1% of cases, and 71% of strains were biofilm-producing. The prevalence of multidrug-resistant (MDR) was alarmingly high (67%), particularly among Escherichia coli (97.3%), Staphylococcus aureus (83.9%), and Proteus mirabilis (90.5%). MDR infections were associated with tobacco use, biofilm formation, polymicrobial infection, and clinical complications. In specific, seven bacterial types, Pseudomonas aeruginosa, Staphylococcus aureus, Providencia rettgeri, Enterococcus faecalis, Enterobacter cloacae, Pseudomonas flourescens, and Staphylococcus epidermidis, as described, were statistically associated with amputation. Beta-lactams (ampicillin, piperacillin) showed 100% resistance. Cephalosporins (ceftazidime, ceftriaxone, cefotaxime, cefepime) had resistance rates ranging from 25 to 96%. Amoxicillin-clavulanic acid showed 30 to 92.3% resistance, while piperacillin-tazobactam ranged from 7.7 to 71.4% resistance. Out of 338 Gram-negative isolates, 105 (31.1%) were ESBL producers, and molecular characterization shows blaCTX-M as the most predominant, 40 (38.1%), followed by blaSHV 20 (19.0%), and blaTEM 7 (6.7%) isolates. Methicillin and vancomycin resistance were common among Gram-positive isolates, particularly Methicillin-resistant Staphylococcus aureus (MRSA) (51.8%) and Vancomycin-resistant Enterococci (VRE) (33.3%). Despite widespread resistance, antibacterial drugs such as colistin (100%), polymyxin B (100%), linezolid (100%), and vancomycin (100%) retained efficacy. These data emphasize the significant burden of MDR infections in DFUs and emphasize the urgent actions needed for aggressive antimicrobial stewardship, early infection control, and personalized treatment approaches to prevent amputation and enhance patient outcomes.Keywords
Funding Information
- the Deanship of Research and Graduate Studies, King Khalid University, Abha, Saudi Arabia (Grant no. R.G.P.2/513/45)
This publication has 51 references indexed in Scilit:
- The diabetic foot ulcer: Biofilm, antimicrobial resistance, and amputationInternational Journal of Diabetes in Developing Countries, 2024
- Biofilm-mediated infections by multidrug-resistant microbes: a comprehensive exploration and forward perspectivesArchives of Microbiology, 2024
- An Update on Diabetic Foot Ulcer and Its Management ModalitiesIndian Journal of Microbiology, 2023
- A clinicopathological study on management of diabetic foot ulcer in tertiary care centreThe Foot, 2023
- Diabetic foot infections: A microbiologic reviewThe Foot, 2022
- Isolation and characterization of bacteria from diabetic foot ulcer: amputation, antibiotic resistance and mortality rateInternational Journal of Diabetes in Developing Countries, 2021
- Assessment of the Risk Factors of Multidrug-Resistant Organism Infection in Adults With Type 1 or Type 2 Diabetes and Diabetic Foot UlcerCanadian Journal of Diabetes, 2020
- Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update)Diabetes/Metabolism Research and Reviews, 2020
- Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical featuresJournal of Advanced Research, 2020
- Severity of drug resistance and co-existence of Enterococcus faecalis in diabetic foot ulcer infectionsFolia Microbiologica, 2017